학술논문

In vitro and in vivo characterization of mct1 inhibitor azd3965 confirms preclinical safety compatible with breast cancer treatment
Document Type
Article
Source
In: Cancers. (Cancers, 1 February 2021, 13(3):1-25)
Subject
Language
English
ISSN
20726694